# Zero Point Five Therapeutics, Inc. — Form D

Zero Point Five Therapeutics, Inc. of BALTIMORE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2025-04-17. The offering totals $5.3M, of which $4.3M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-04-17
- Form: D
- Accession: 0002054934-25-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.3M
- Amount sold: $4.3M
- Remaining: $1.0M
- Investors: 10
- Date of first sale: 2025-04-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-543974

## Issuer

- Name: Zero Point Five Therapeutics, Inc.
- CIK: 0001985295
- Entity type: Corporation
- Jurisdiction: DISTRICT OF COLUMBIA
- Incorporated: 2018
- Address: 915 S. EATON STREET, BALTIMORE, MD, 21224
- Phone: 301-327-0118

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Joseph Amprey III | Director | Baltimore, MD |
| Ben Auspitz | Director | Cambridge, MA |
| Jodi Jahic | Director | Baltimore, MD |
| Joseph Amprey III | Executive Officer | Baltimore, MD |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2023-07-12](https://search.stillhousedata.com/formd/0001985295-23-000001) | D | $10.1M | $7.2M |

## More

- [CIK 1985295 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1985295&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002054934-25-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.